Based on PubMed | What causes heart palpitations in people with head and neck cancer, and do these symptoms affect overall prognosis?

Heart palpitations in people with head and neck cancer often have more than one cause. The most common drivers include cancer treatments (such as chemotherapy and immunotherapy), anemia, infection, dehydration, pain/anxiety, thyroid problems from immunotherapy, and pre‑existing heart disease; less commonly, hormone‑secreting tumors (paragangliomas) or blood clots can be involved. ^[1] While palpitations themselves don’t automatically mean a worse cancer prognosis, certain heart problems and cardiovascular events in this population are linked to higher overall mortality, so they deserve prompt evaluation and management. ^{[2] [3]}

Why palpitations happen

• Chemotherapy and infusion drugs

  • 5‑fluorouracil (5‑FU) and cisplatin can irritate the heart’s electrical system or blood supply, causing chest pain, ECG changes, and arrhythmias during treatment. ^[4] Close monitoring and stopping the drug are often advised if chest pain or arrhythmias occur. ^[4]
  • Regimens combining platinum agents, fluorouracil, and immune therapy include warnings about abnormal heartbeat, chest pain, and shortness of breath and recommend urgent assessment for these symptoms. ^[5] Heart problems can occur early (weeks) and sometimes even after treatment ends. ^[6]

• Immunotherapy (checkpoint inhibitors such as pembrolizumab)

  • Immune‑related heart side effects include myocarditis, cardiomyopathy, and arrhythmias; although uncommon, they can be serious or life‑threatening. ^[7] In a large head and neck cancer cohort on immunotherapy, new tachyarrhythmias were the most frequent cardiovascular diagnosis and often triggered emergency care. ^[8]
  • Immunotherapy can also inflame the thyroid, first causing overactive thyroid (hyperthyroidism) with fast or irregular heartbeat and sweating, and later underactive thyroid (hypothyroidism) with slow heart rate and fatigue. ^[9] Programs typically run regular blood tests to check thyroid function during therapy. ^[9]

• Non‑drug contributors common in cancer care

  • Anemia, infection, dehydration, pain, anxiety, and elevated inflammatory signals can drive sinus tachycardia and palpitations in people with cancer. ^[1] Cancer‑related resting sinus tachycardia can reflect increased metabolic demand or complications like clots or infection, so dangerous causes should be ruled out. ^[10]

• Rare tumor‑related causes

  • Paragangliomas (neuroendocrine tumors that can arise in the head and neck) may secrete catecholamines, leading to episodic palpitations, high blood pressure, sweating, and headaches. ^[11] Head and neck paragangliomas are often non‑secreting, but hormone‑producing cases can cause severe cardiovascular symptoms and need specialized care. ^[12]

• Pre‑existing heart disease and risk factors

  • Many people with head and neck cancers have smoking history, hypertension, diabetes, and other risk factors that predispose to arrhythmias and ischemic heart disease. ^[3] These factors increase the likelihood that palpitations reflect a true cardiac problem. ^[3]

---

Do palpitations affect prognosis?

• Symptom alone vs underlying diagnosis

  • Palpitations as a symptom do not necessarily predict cancer survival by themselves. However, when palpitations reflect significant heart disease (e.g., myocarditis, myocardial infarction, or sustained arrhythmias), they are associated with worse overall outcomes. ^[2]
  • In a large veterans’ cohort with head and neck cancer, incident stroke and myocardial infarction were linked to a 47% and 71% higher risk of death, respectively, highlighting the impact of cardiovascular events on survival. ^[3] This underscores why new heart symptoms warrant timely evaluation and risk‑factor control. ^[3]

• Immunotherapy‑related events

  • Myocarditis after immunotherapy often occurs within the first few months and can be life‑threatening; tachyarrhythmias are common in this setting and frequently prompt emergency visits. ^[8] Early recognition and treatment of immune‑mediated heart toxicity can be critical for both cardiac and oncologic outcomes. ^[8]

• Overall cardiovascular burden in head and neck cancer

  • Cardiovascular disease accounts for a notable fraction of deaths in head and neck cancer populations, with risk peaking in the first five years after diagnosis and higher in those with advanced stage or untreated disease. ^[13] Better control of blood pressure, lipids, diabetes, and smoking cessation is associated with fewer events and may improve survival. ^[3]

---

What to watch for and when to act

• Red‑flag symptoms

  • Chest pain, tightness, shortness of breath, new swelling of the ankles, fainting, or a racing/irregular heartbeat should prompt immediate medical attention during or after treatment. ^[6] Treatment programs advise urgent evaluation for these symptoms because heart problems may be uncommon but can be serious. ^[14]

• Thyroid‑related clues

  • Feeling unusually hot, sweating, weight loss, tremor, anxiety, and a fast heartbeat can suggest hyperthyroidism during immunotherapy, whereas fatigue, weight gain, feeling cold, and slow heart rate can point to hypothyroidism. ^[9] Routine thyroid testing during therapy helps catch these problems early. ^[9]

---

Practical evaluation pathway

• Initial checks

  • History focused on timing with infusions, associated fever, pain, dehydration, or anxiety; vital signs; 12‑lead ECG; and basic labs (complete blood count for anemia, electrolytes, thyroid‑stimulating hormone/free T4, inflammatory markers if infection suspected). ^[1] This approach mirrors general palpitation workups but accounts for cancer‑specific triggers. ^[1]

• When to broaden testing

  • If ECG is abnormal or symptoms are severe or persistent, consider troponin testing and echocardiography to assess for myocarditis or cardiomyopathy in those on immunotherapy. ^[7] Ambulatory monitoring can help capture intermittent arrhythmias when initial ECG is normal. ^[1]
  • If there are signs of pulmonary embolism (sudden shortness of breath, chest pain, low oxygen), pursue imaging based on clinical probability since clots can cause tachycardia and palpitations in cancer. ^[10] Addressing reversible causes like dehydration or infection is equally important. ^[10]
  • If there are paroxysms of palpitations with headaches, sweating, and hypertension, evaluate for catecholamine‑secreting paraganglioma (plasma‑free or urine metanephrines) and image appropriately. ^[11] Specialist, multidisciplinary management is recommended when paraganglioma is suspected. ^[15]

---

Treatment and prevention

• Manage the cause

  • Adjust or pause cardiotoxic chemotherapy if chest pain or arrhythmia develops, under oncology and cardio‑oncology guidance. ^[4] For immune‑mediated myocarditis or arrhythmias, early steroids and coordinated care can be lifesaving. ^[7]
  • Treat anemia, infection, and dehydration; optimize electrolytes; and consider beta‑blockers or calcium‑channel blockers when appropriate for symptomatic control after ruling out dangerous causes. ^[1] Thyroid dysfunction should be treated per standard thyroid protocols while continuing cancer care when safe. ^[9]

• Cardiovascular risk reduction

  • Control blood pressure, diabetes, and lipids; support smoking cessation; and maintain activity as tolerated to lower the risk of stroke and heart attack, which are linked to higher mortality in head and neck cancer. ^[3] Regular follow‑up for heart risk factors is a key part of survivorship care. ^[3]

---

Quick reference table

Cause	Typical clues	What to check	Why it matters
5‑FU/cisplatin toxicity	Palpitations during infusion cycles, chest pain	ECG, troponin, consider holding drug	Can cause ischemia/arrhythmias; stop drug if events occur [4]
Immunotherapy myocarditis/arrhythmia	Within months of starting immunotherapy	ECG, troponin, echo, consider MRI	Uncommon but serious; early treatment improves outcomes [7] [8]
Thyroiditis from immunotherapy	Heat intolerance, tremor, weight change, fast or slow pulse	TSH/free T4	Common irAE; treat thyroid dysfunction [9]
Anemia/infection/dehydration	Fatigue, fever, low BP, recent illness	CBC, cultures as indicated, electrolytes	Frequent in cancer; correcting reverses tachycardia [1]
Pulmonary embolism	Sudden dyspnea, chest pain, hypoxia	Risk stratify; imaging if indicated	Life‑threatening; causes tachycardia [10]
Paraganglioma (catecholamine‑secreting)	Episodic palpitations, headaches, sweating, hypertension	Plasma/urine metanephrines; imaging	Requires specialized care; can cause crises [11] [15]

---

Key takeaways

• Palpitations in head and neck cancer are common and often multifactorial, with treatment toxicity, thyroid issues, anemia/infection, and cardiovascular risk factors leading the list. ^{[1] [9]}
• While palpitations alone don’t define prognosis, cardiovascular events such as myocarditis, stroke, myocardial infarction, and sustained arrhythmias are linked to higher mortality in this population, so timely evaluation is important. ^{[8] [3]}
• Controlling heart risk factors and promptly managing treatment‑related cardiotoxicity can help reduce complications and may improve overall outcomes. ^{[3] [7]}